Published in Cancer Epidemiol Biomarkers Prev on October 01, 1998
Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 2.09
Environmental exposures and puberty in inner-city girls. Environ Res (2008) 1.43
Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin Chem (2013) 1.37
Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res (2008) 1.04
Dietary flavonol intake is associated with age of puberty in a longitudinal cohort of girls. Nutr Res (2013) 0.91
Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer (2004) 0.90
Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC. Cancer Causes Control (2012) 0.79
Reliability of serum and urinary isoflavone estimates. Biomarkers (2010) 0.79
Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer. Eur J Clin Nutr (2017) 0.75
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature (1994) 2.49
Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol (1998) 2.30
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A (1993) 2.09
Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer (2004) 2.05
Serum carotenoids and breast cancer. Am J Epidemiol (2001) 2.02
Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol (2003) 1.93
Evaluation of Fecatest, a new guaiac test for occult blood in feces. Clin Chem (1978) 1.91
Effect of training on plasma anabolic and catabolic steroid hormones and their response during physical exercise. Int J Sports Med (1986) 1.91
Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med (1970) 1.88
Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci (2001) 1.87
Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst (1994) 1.85
Immunological detection of faecal occult blood in colorectal cancer. Br J Cancer (1984) 1.84
Serum insulin-like growth factor-I and breast cancer. Int J Cancer (2000) 1.82
Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med (1982) 1.77
Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev (2000) 1.70
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol (2004) 1.63
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res (1997) 1.58
Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer (2000) 1.56
Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4). J Nutr (2001) 1.55
A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect (1998) 1.55
Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol (2000) 1.54
Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet (2000) 1.53
Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer (1999) 1.52
Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer (2001) 1.48
Prospective study of diet and female colorectal cancer: the New York University Women's Health Study. Nutr Cancer (1997) 1.43
Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc (1994) 1.42
DNA-protein cross-links in welders: molecular implications. Cancer Res (1993) 1.41
Functional significance of different human CYP1A1 genotypes. Carcinogenesis (1994) 1.40
The "Fecatwin Sensitive" test for fecal occult blood is not intended for use without testing positives with the FECA-EIA assay. Clin Chem (1989) 1.39
Psychosocial stress and the insulin resistance syndrome. Metabolism (1996) 1.37
The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr (1986) 1.35
Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr (1998) 1.34
Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol (1990) 1.32
Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med (1981) 1.31
Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem (1986) 1.30
Aspirin and epithelial ovarian cancer. Prev Med (2001) 1.30
The estimated frequency of cosmetic breast augmentation among US women, 1963 through 1988. Am J Public Health (1995) 1.29
Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr (1995) 1.27
In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem (2001) 1.25
Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A (1998) 1.24
Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. Int J Cancer (1999) 1.24
Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer (2001) 1.23
Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr (2000) 1.21
Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol (1997) 1.20
Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol (1999) 1.19
A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev (2001) 1.19
Aspirin and lung cancer in women. Br J Cancer (2002) 1.18
Urinary coproporphyrin isomer distribution in the Dubin-Johnson syndrome. Clin Chem (1967) 1.17
In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol (1993) 1.17
Dietary phyto-oestrogens and the menopause in Japan. Lancet (1992) 1.15
Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2001) 1.14
A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res (1995) 1.13
A method for the quantitative determination of urinary estriol conjugates in human pregnancy. J Steroid Biochem (1972) 1.12
Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol (1994) 1.11
Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.11
Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem (1980) 1.10
Antioxidants in vegan diet and rheumatic disorders. Toxicology (2000) 1.10
Reliability of fatty acid composition in human serum phospholipids. Eur J Clin Nutr (2000) 1.09
Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev (2001) 1.07
Effect of diet on excretion of estrogens in pre- and postmenopausal women. Cancer Res (1981) 1.07
Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci (2001) 1.07
Determinants of serum enterolactone concentration. Am J Clin Nutr (2001) 1.05
A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid. Cancer Epidemiol Biomarkers Prev (2000) 1.05
Letter: Effects of exertion on hormone secretion. Br Med J (1975) 1.05
Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? Br J Cancer (2000) 1.04
A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. Int J Cancer (2001) 1.04
Epidemiologic correlates with menstrual cycle length in middle aged women. Eur J Epidemiol (1999) 1.04
Androgens and breast cancer in premenopausal women. Cancer Res (1989) 1.03
Plasma cortisol, androstenedione, testosterone and luteinizing hormone in running exercise of different intensities. Scand J Clin Lab Invest (1980) 1.03
Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res (1991) 1.02
Comparison of active and cancer registry-based follow-up for breast cancer in a prospective cohort study. Am J Epidemiol (1999) 1.01
Lignans in man and in animal species. Nature (1980) 1.01
Intestinal metabolism of estrogens. J Clin Endocrinol Metab (1976) 1.01
Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health (1993) 1.01
Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet (1982) 1.00
Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate (2000) 1.00
Diet, smoking and anthropometric indices and postmenopausal bone fractures: a prospective study. Int J Epidemiol (2000) 0.99
Serum carotenoids as biomarkers of fruit and vegetable consumption in the New York Women's Health Study. Public Health Nutr (2001) 0.99
Increased DNA-protein crosslinks in lymphocytes of residents living in chromium-contaminated areas. Biol Trace Elem Res (1995) 0.99
Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab (1998) 0.99
In vitro metabolism of estrogens by isolated intestinal micro-organisms and by human faecal microflora. J Steroid Biochem (1980) 0.98
Hepatic metabolism of estrogens in health and disease. N Engl J Med (1974) 0.98